Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remission

BACKGROUND: Patients with aggressive lymphoma achieving complete remission (CR) after first-line combination chemotherapy undergo regular surveillance to detect relapse. Current international guidelines recommend routine follow-up blood tests in this context, but evidence supporting this practice is...

Descripción completa

Detalles Bibliográficos
Autores principales: Hawkes, Eliza A, Loh, Zoe, Estacio, Ortis, Chong, Geoff, Ha, Francis J, Gilbertson, Michael, Grigg, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162229/
https://www.ncbi.nlm.nih.gov/pubmed/30033446
http://dx.doi.org/10.1038/s41416-018-0183-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162229/
https://www.ncbi.nlm.nih.gov/pubmed/30033446
http://dx.doi.org/10.1038/s41416-018-0183-x

Ejemplares similares